These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3470054

  • 1. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Blood; 1987 Apr; 69(4):1134-40. PubMed ID: 3470054
    [Abstract] [Full Text] [Related]

  • 2. An in vitro model to predict clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Burke PJ.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):172-81. PubMed ID: 3473676
    [Abstract] [Full Text] [Related]

  • 3. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 4. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
    Karp JE, Burke PJ, Donehower RC.
    Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
    [Abstract] [Full Text] [Related]

  • 5. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M.
    Leuk Res; 1993 Jul; 17(7):585-92. PubMed ID: 8326741
    [Abstract] [Full Text] [Related]

  • 6. In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia.
    Karp JE, Donehower RC, Enterline JP, Dole GB, Fox MG, Burke PJ.
    Blood; 1989 Jan; 73(1):24-30. PubMed ID: 2910362
    [Abstract] [Full Text] [Related]

  • 7. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G, Reuter C, Unterhalt M, Schleyer E, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Hug V, Keating MJ, Chubb S.
    Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239
    [Abstract] [Full Text] [Related]

  • 9. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
    Boos J, Hohenlöchter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jurgens H.
    Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 11. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

  • 12. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M, Hohenlöchter B, Schulze-Westhoff P, Zimmermann M, Ritter J, Jürgens H, Boos J.
    Klin Padiatr; 1996 Feb; 208(4):151-9. PubMed ID: 8926681
    [Abstract] [Full Text] [Related]

  • 13. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
    Bhalla K, Holladay C, Arlin Z, Grant S, Ibrado AM, Jasiok M.
    Blood; 1991 Nov 15; 78(10):2674-9. PubMed ID: 1824260
    [Abstract] [Full Text] [Related]

  • 14. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 15; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.
    Gandhi V, Xu YZ, Estey E.
    Clin Cancer Res; 1998 Jul 15; 4(7):1719-26. PubMed ID: 9676847
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
    Yang JL, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1992 Jul 15; 29(3):236-40. PubMed ID: 1733557
    [Abstract] [Full Text] [Related]

  • 19. [Relation between plasma Ara-C and intracellular Ara-CTP levels by intermediate dose and high dose Ara-C administration in the treatment of AML].
    Yoshida T, Kobayashi K, Nakamura S, Ohtake S, Itoh K, Kanno M, Hirai J, Yasushi, Matsuda TT.
    Gan To Kagaku Ryoho; 1988 Apr 15; 15(4 Pt 1):625-30. PubMed ID: 3162669
    [Abstract] [Full Text] [Related]

  • 20. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.
    Gandhi V, Estey E, Keating MJ, Chucrallah A, Plunkett W.
    Blood; 1996 Jan 01; 87(1):256-64. PubMed ID: 8547650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.